1. Home
  2. MBC vs ABCL Comparison

MBC vs ABCL Comparison

Compare MBC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MasterBrand Inc.

MBC

MasterBrand Inc.

HOLD

Current Price

$9.34

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.93

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBC
ABCL
Founded
1954
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
MBC
ABCL
Price
$9.34
$3.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$15.00
$8.40
AVG Volume (30 Days)
1.6M
4.5M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
0.21
N/A
Revenue
$2,734,700,000.00
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.55
$21.85
P/E Ratio
$45.05
N/A
Revenue Growth
1.27
160.56
52 Week Low
$7.38
$1.94
52 Week High
$14.22
$6.52

Technical Indicators

Market Signals
Indicator
MBC
ABCL
Relative Strength Index (RSI) 58.65 57.42
Support Level $9.33 $3.91
Resistance Level $13.29 $4.76
Average True Range (ATR) 0.32 0.22
MACD 0.12 0.03
Stochastic Oscillator 76.00 53.33

Price Performance

Historical Comparison
MBC
ABCL

About MBC MasterBrand Inc.

MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: